FindTrial
Sign In

Predictive value of ultrasound O-RADS score for benign and malignant ovarian plasma tumors

Predictive value of ultrasound O-RADS score for benign and malignant ovarian plasma tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060649
Enrollment
Unknown
Registered
2022-06-06
Start date
2022-05-31
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian tumors

Interventions

Group 1:Benign tumors vs. non-benign tumors
Group 2:Borderline tumors vs. malignant tumors
Group 3:Early-staging vs Advenced staging

Sponsors

The First Affiliated Hospital of Dalian Medical University, Department of Gynecology and Obstetrics
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Ovarian plasmacytoma (benign, junctional, malignant); 2. Satisfactory and reliable ultrasound findings; 3. No sexual neoadjuvant chemotherapy and other relevant treatment prior to data collection

Exclusion criteria

Exclusion criteria: 1. Ovarian tumor of other tissue origin; 2. Unsatisfactory evaluation of ultrasound findings

Design outcomes

Primary

MeasureTime frame
O-RADS score;—

Countries

China

Contacts

Public ContactFandou Kong

The First Hospital of Dalian Medical University

zesiliu@163.com+86 18098876369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026